January 24, 2015

Effect of Pentoxifylline on Renal Function and Urinary Albumin Excretion in Patients with Diabetic KidneyDisease: The PREDIAN Trial.

.   .   

This open-label prospective, randomized trial showed that pentoxifylline in addition to RAS inhibitors resulted in a smaller decrease in eGFR and great reduction of albuminuria at two years in Type 2 diabetics with stage 3-4 CKD.

Related Articles:

Chronic Kidney Disease, Clinical Nephrology, Clinical Trial Results, General Nephrology
  • alan friedman

    What is the consensus feeling re this? Is it something to truly implement ie feeling among the nephrology comminity?